coronavirus
cov
import
human
pathogen
signific
zoonot
potenti
progress
made
toward
identifi
potenti
vaccin
candid
highli
pathogen
human
cov
includ
use
attenu
virus
lack
cov
envelop
e
protein
express
e
mutant
howev
approv
vaccin
antivir
therapeut
exist
cov
assembl
bud
lumen
earli
golgi
prior
exocytosi
small
cov
e
protein
play
role
assembl
virion
releas
pathogenesi
cov
e
singl
hydrophob
domain
hd
target
golgi
membran
cation
channel
activ
vitro
e
protein
avian
infecti
bronchiti
viru
ibv
dramat
effect
secretori
system
requir
residu
hd
mutat
hd
ibv
e
infect
result
impair
growth
kinet
impair
releas
infecti
virion
accumul
ibv
protein
plasma
membran
compar
ibv
wt
infect
cell
aberr
cleavag
ibv
surfac
virion
previous
report
format
two
distinct
oligomer
pool
ibv
e
transfect
infect
cell
disrupt
secretori
pathway
ibv
e
correl
form
like
monomer
suggest
effect
secretori
pathway
independ
e
ion
channel
activ
present
evid
suggest
monomer
form
ibv
e
correl
rise
ph
golgi
lumen
demonstr
infect
ibv
induc
neutral
golgi
lumin
ph
promot
model
ibv
e
alter
secretori
pathway
interact
host
cell
factor
protect
ibv
spike
protein
prematur
cleavag
lead
effici
releas
infecti
viru
cell
major
human
coronavirus
cov
caus
mild
diseas
phenotyp
howev
novel
coronavirus
like
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
cov
emerg
anim
reservoir
infect
human
elicit
robust
aberr
immun
respons
lead
seriou
deadli
pneumonia
importantli
effect
vaccin
therapeut
treat
cov
effort
develop
longterm
therapeut
strategi
combat
novel
highli
pathogen
cov
aid
increas
understand
conserv
viral
mechan
level
cell
molecular
biolog
one
fascin
rel
enigmat
aspect
cov
biolog
cov
virion
bud
lumen
secretori
pathway
endoplasm
reticulumgolgi
intermedi
compart
ergic
must
navig
golgi
anterograd
endomembran
system
effici
releas
host
cell
demonstr
structur
function
golgi
depend
upon
acid
ph
gradient
decreas
lumen
cisgolgi
lumen
transgolgi
ph
gradient
produc
balanc
maintain
proton
influx
lumen
golgi
proton
leak
counterion
conduct
pharmacolog
manipul
ph
gradient
result
neutral
lumen
shown
caus
slow
traffick
cargo
golgi
well
alter
golgi
morpholog
class
small
viral
membran
protein
ion
channel
activ
call
viroporin
shown
dramat
effect
secretori
pathway
similar
elicit
pharmacolog
manipul
lumin
ph
sever
wellstudi
member
viroporin
famili
protein
includ
influenza
protein
iav
hepat
c
viru
hcv
protein
cov
envelop
e
protein
repres
viroporin
demonstr
sever
common
function
featur
despit
differ
viral
assembl
bud
locat
suggest
role
secretori
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
pathway
neutral
lumin
ph
protect
ha
fusion
protein
influenza
prematur
activ
overexpress
caus
secretori
pathway
disrupt
rate
intracellular
traffick
slow
golgi
morpholog
alter
hcv
also
thought
play
protect
role
allow
egress
viral
structur
protein
secretori
pathway
hcv
partial
rescu
pharmacolog
neutral
lumin
space
bafilomycin
tran
express
iav
similar
infecti
bronchiti
viru
ibv
coronaviru
e
protein
elicit
multipl
secretori
pathway
disrupt
phenotyp
overexpress
mammalian
cell
understand
cov
e
cell
biolog
level
recombin
viru
system
use
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ibv
e
reduc
traffick
rate
membran
secretori
cargo
given
releas
infecti
ibv
reduc
surpris
wildtyp
e
protein
reduc
cargo
traffick
hypothes
sinc
hd
requir
alter
lumen
e
ion
channel
activ
requir
maintain
intact
viru
reduc
rate
traffick
accept
compromis
viru
studi
probe
natur
cov
e
ion
channel
activ
center
understand
residu
requir
activ
associ
pathogen
cell
biolog
phenotyp
elicit
differ
cov
e
protein
two
residu
hd
sarscov
e
shown
promot
viral
fit
infect
mutat
abolish
ionchannel
activ
sarscov
e
artifici
membran
previous
report
e
protein
ibv
express
mammalian
cell
found
two
pool
veloc
gradient
analysi
low
molecular
weight
pool
lmw
high
molecular
weight
pool
hmw
lmw
pool
repres
ibv
e
monomer
state
hmw
pool
correl
homooligom
ibv
e
mutat
correspond
conserv
hd
residu
sarscov
e
inhibit
ion
channel
activ
made
ibv
e
found
hd
mutant
segreg
primarili
one
oligomer
pool
e
mutant
primarili
hmw
pool
e
mutant
found
primarili
lmw
pool
presenc
lmw
pool
ibv
e
predomin
like
monomer
form
found
e
present
correl
secretori
pathway
disrupt
associ
wt
ibv
e
protein
surpris
suggest
e
ion
channelindepend
role
ibv
e
associ
manipul
secretori
pathway
recent
report
hd
mutant
abolish
ion
channel
activ
ibv
e
artifici
membran
viru
titer
reduc
log
supernat
infect
cell
suggest
defect
virion
releas
data
viru
corrobor
studi
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
herein
provid
evid
neutral
golgi
ibv
infect
demonstr
transient
overexpress
ibv
e
protein
hd
mutant
defici
lmw
pool
ibv
e
suffici
caus
signific
increas
ph
golgi
lumen
suggest
increas
traffick
aberr
cleavag
ibv
protein
observ
ibv
infect
may
reflect
detriment
effect
normal
ph
ibv
process
demonstr
ibv
process
traffick
similarli
aberr
coexpress
wt
e
iav
substitut
wt
e
protect
prematur
cleavag
given
effect
ibv
e
overexpress
golgi
similar
cell
lumin
ph
neutral
first
measur
lumin
ph
ibvinfect
cell
use
flow
cytometr
analysi
ratiometr
phluorin
molecul
target
golgi
report
consist
green
fluoresc
protein
gfp
phluorin
molecul
fuse
membran
target
sequenc
transgolgi
network
resid
protein
chose
use
transgolgi
network
phluorin
tgn
acid
compart
golgi
thu
alter
ph
would
like
detect
compart
gener
clonal
vero
cell
line
stabli
express
figur
gener
cell
line
allow
us
ensur
infect
cell
express
cell
treat
cycloheximid
minut
chase
newli
synthes
er
gener
ph
calibr
curv
cell
express
golgi
phluorin
molecul
subject
treatment
buffer
rang
ph
presenc
ionophor
monensin
nigericin
prior
flow
analysi
figur
emiss
ratio
biphas
phsensit
phluorin
known
ph
valu
use
predict
golgi
lumin
ph
cell
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
infect
ibv
buffer
physiolog
ph
lack
ionophor
figur
infect
result
robust
increas
golgi
lumin
ph
attempt
measur
golgi
lumin
ph
cell
infect
unabl
achiev
high
percent
infect
cell
absenc
syncytium
format
sinc
viru
effici
releas
spread
best
cellcel
fusion
found
syncytia
fragil
preclud
flow
cytometr
analysi
instead
turn
transfect
cell
determin
e
protein
could
neutral
golgi
lumen
determin
ph
chang
infect
cell
caus
e
protein
hela
cell
cotransfect
plasmid
encod
ibv
e
along
report
use
transient
transfect
report
ensur
phluorin
express
cell
also
express
e
protein
separ
cell
includ
vector
alon
plasmid
encod
ibv
anoth
overexpress
golgi
membran
protein
control
describ
transfect
cell
pretreat
cycloheximd
min
chase
newli
synthes
er
standard
curv
produc
cell
treat
ionophor
calibr
ph
buffer
shown
fig
c
ibv
e
neutral
transgolgi
lumin
ph
express
hela
cell
wherea
ibv
protein
determin
role
ibv
e
oligomer
alter
golgi
lumin
ph
analyz
two
hd
point
mutant
ibv
e
segreg
differ
oligomer
state
previou
find
suggest
ibv
e
found
predominantli
lmw
like
monomer
form
ibv
e
found
predominantli
hmw
higherord
oligom
addit
analyz
mutant
ibv
e
entir
hd
ibv
e
replac
heterolog
hd
sequenc
ibv
e
ibv
ph
measur
similar
ibv
membran
protein
control
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ph
ph
respect
ibv
e
elicit
robust
ph
increas
similar
wildtyp
ibv
e
protein
ph
figur
suggest
lmw
pool
ibv
e
correl
lumin
ph
increas
golgi
addit
secretori
pathway
disrupt
demonstr
previou
work
experi
perform
medialgolgi
phluorin
nacetylglucosaminyltransferas
assess
alter
ph
specif
tgn
inde
ibv
e
ibv
e
elicit
robust
ph
increas
figur
interest
ibv
e
increas
ph
significantli
though
robustli
ibv
e
ibv
e
found
ph
transgolgi
measur
higher
medialgolgi
measur
unexpect
address
discuss
result
transfect
cell
implic
monomer
form
ibv
e
neutral
golgi
lumen
infect
transfect
attempt
rescu
ibv
manipul
golgi
ph
despit
intens
effort
unabl
conclus
determin
whether
increas
golgi
ph
could
rescu
defici
ibv
viru
tri
drug
neutral
acid
compart
baflinomycin
monensin
ammonium
chlorid
well
overexpress
influenza
ph
activ
proton
channel
howev
drug
inhibit
exocytosi
concentr
use
short
long
infect
unabl
obtain
high
percentag
cell
subsequ
infect
sever
experi
percent
transfect
infect
cell
greater
obtain
increas
releas
infecti
viru
experi
fail
show
reason
overlap
transfect
infect
rescu
infect
data
shown
addit
attempt
make
stabl
line
express
phluorin
yield
line
express
high
enough
level
alter
golgi
ph
thu
turn
anoth
approach
assess
role
neutral
golgi
ibv
e
infect
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
cell
surfac
ibv
protein
cleav
furinlik
proteas
gener
subunit
traffick
golgi
second
site
prime
protein
fusion
host
cell
protein
subject
proteolysi
near
junction
protein
viral
envelop
result
ctermin
fragment
term
stub
predict
neutral
golgi
ph
ibv
e
infect
protect
ibv
protein
prematur
proteolysi
normal
acid
ph
transgolgi
also
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
presenc
also
observ
cell
surfac
though
differ
signific
valu
differ
cell
type
rang
ph
believ
slightli
higher
baselin
measur
observ
like
due
plasma
membran
cycl
would
increas
averag
ph
given
cell
sinc
ph
extra
cellular
buffer
ph
cycl
like
predomin
reason
higher
expect
tgn
ph
sinc
medialgolgi
phluorin
report
ph
believ
consist
shift
golgi
ph
cell
express
ibv
e
import
actual
baselin
ph
valu
observ
previous
construct
use
demonstr
howev
ibv
e
ibv
hd
mutant
caus
statist
signific
shift
ph
unit
respect
previous
show
lmw
pool
ibv
e
correl
secretori
pathway
disrupt
includ
golgi
disassembl
slow
traffick
model
cargo
protein
observ
wildtyp
ibv
e
protein
express
hypothes
golgi
disrupt
like
occur
ibv
e
ion
channelindepend
manner
studi
corrobor
hypothesi
suggest
proteolyt
process
two
cleavag
site
releas
protein
prefus
conform
allow
conform
chang
expos
fusion
peptid
chang
conform
may
also
releas
subunit
subunit
cov
trimer
possibl
detriment
consequ
normal
acid
golgi
ph
viru
could
protein
subject
conform
chang
prematur
possibl
excess
proteolyt
process
result
releas
subunit
prior
receptor
bind
would
result
noninfecti
impair
virion
demonstr
ibv
overexpress
cell
presenc
level
ibv
cleavag
speci
increas
significantli
compar
ibv
presenc
ibv
e
iav
lend
support
hypothesi
neutral
golgi
ph
ibv
e
protect
ibv
prematur
cleavag
addit
express
cell
ibv
present
greater
extent
cell
surfac
corrobor
previou
data
observ
ibv
infect
strike
ibv
e
compar
notion
ibv
e
like
caus
secretori
pathway
disrupt
ibv
e
ionchannel
independ
way
ibv
e
act
monom
elicit
secretori
pathway
disrupt
alter
ph
interact
ibv
e
host
protein
lipid
would
necessari
evid
suggest
cov
e
protein
interact
host
cell
protein
influenc
pathogen
interact
sarscov
e
pdz
postsynapt
densiti
largezonula
domain
contain
scaffold
protein
syntenin
tight
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
larg
amount
ibv
e
known
resid
ergic
could
disrupt
ph
directli
indirectli
interf
normal
secret
architectur
golgi
summari
studi
address
cov
e
proteinprotein
proteinlipid
interact
develop
tool
evalu
ionchannel
activ
vivo
go
long
way
elucid
precis
mechan
multifunct
famili
viroporin
protein
antibodi
rabbit
polyclon
antibodi
recogn
cterminu
ibv
e
ntermin
head
previous
describ
antibodi
gener
cterminu
ibv
also
describ
mous
monoclon
antibodi
recogn
nterminu
influenza
previous
describ
gener
gift
dr
andrew
pekosz
mous
antigfp
antibodi
roch
mannheim
germani
rabbit
antigfp
antibodi
thermo
fisher
scientif
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
glycerol
contain
npropylgal
imag
captur
use
axioskop
microscop
zeiss
equip
epifluoresc
chargecoupleddevic
camera
hamamatsu
japan
ivis
softwar
bio
vision
technolog
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ph
use
gener
linear
calibr
curv
microsoft
excel
calcul
lumin
golgi
ph
infect
uninfect
cell
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
millipor
block
mm
trishcl
ph
nacl
tb
plu
nonfat
milk
membran
probe
rabbit
antiibv
dilut
tween
tbstw
band
detect
donkey
antirabbit
licor
dilut
tbstw
imag
use
licor
odyssey
clx
quantif
perform
imag
studio
licor
ibv
fragment
express
percent
total
input
surfac
fraction
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
label
rabbit
antigfp
mous
follow
alexa
antirabbit
igg
alexa
antimous
igg
hoescht
stain
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
